Publication | Open Access

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

Phase 1/2Graft-versus-host DiseaseTransplantationMarrow TransplantationStem Cell TransplantationHematologyImmunologyGraft SurvivalBlood TransplantationImmunotherapyMedicineCell TransplantationGraft Rejection